Literature DB >> 6839909

A radioimmunoassay for cholecystokinin (CCK).

F P Brooks.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6839909     DOI: 10.1007/bf02430536

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  7 in total

1.  Antibodies to the C-terminal tetrapeptide amide of gastrin. Assessment of antibody binding to cholecystokinin-pancreozymin.

Authors:  J E McGuigan
Journal:  Gastroenterology       Date:  1968-06       Impact factor: 22.682

2.  Immunochemical measurement of elevated levels of gastrin in the serum of patients with pancreatic tumors of the Zollinger-Ellison variety.

Authors:  J E McGuigan; W L Trudeau
Journal:  N Engl J Med       Date:  1968-06-13       Impact factor: 91.245

3.  Peptide radioimmunoassays in clinical medicine.

Authors:  M C Geokas; R S Yalow; E W Straus; E M Gold
Journal:  Ann Intern Med       Date:  1982-09       Impact factor: 25.391

4.  Cholecystokinin-octapeptidelike immunoreactivity in human plasma.

Authors:  J H Walsh; C B Lamers; J E Valenzuela
Journal:  Gastroenterology       Date:  1982-03       Impact factor: 22.682

5.  Radioimmunoassay of cholecystokinin in human plasma.

Authors:  D J Byrnes; L Henderson; T Borody; J F Rehfeld
Journal:  Clin Chim Acta       Date:  1981-03-19       Impact factor: 3.786

6.  Identification and measurement of molecular variants of cholecystokinin in duodenal mucosa and plasma. Diminished concentrations in patients with celiac disease.

Authors:  J Calam; A Ellis; G J Dockray
Journal:  J Clin Invest       Date:  1982-01       Impact factor: 14.808

7.  Radioimmunoassay of cholecystokinin-pancreozymin.

Authors:  R F Harvey; L Dowsett; M Hartog; A E Read
Journal:  Gut       Date:  1974-09       Impact factor: 23.059

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.